title: [Thrombosis caused by active rapamycin stents].
abstract: We report the case history of a patient aged 68 years presenting with a recurrence of anterior myocardial infarction complicated by cardiogenic shock with a thrombosis of an active rapamycin stent 77 days following the angioplasty procedure. This was provoked by stopping platelet anti-aggregant treatment, a diabetic background and in the context of scheduled surgery for cancer recurrence. Recent data in the literature combined with our observations prompt the continuation of anti-aggregant bi therapy for at least 9 months after endoprosthesis insertion even if an active stent is used. In the case where surgery is envisaged, it is necessary to wait at least 6 months after the rapamycin stent revascularisation procedure. If an extra-cardiac procedure is envisaged during the angioplasty, it would be preferable to not use an active stent.
authors.affiliation: Département de cardiologie médicale, institut de cardiologie, Paris.
authors.forename: R
authors.initials: R
authors.lastname: Aoudia-Mentfakh
authors.forename: F
authors.initials: F
authors.lastname: Raoux
authors.forename: J P
authors.initials: JP
authors.lastname: Collet
authors.forename: M H
authors.initials: MH
authors.lastname: Fléron
authors.forename: G
authors.initials: G
authors.lastname: Drobinski
authors.forename: J P
authors.initials: JP
authors.lastname: Metzger
authors.forename: C
authors.initials: C
authors.lastname: Le Feuvre
mesh_terms: D000368:Aged; D016503:Drug Delivery Systems / Q000009:adverse effects*; D005260:Female; D006801:Humans; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects*; D013927:Thrombosis / Q000209:etiology*
chemical_list: D020123:Sirolimus